![1]()
News
Guideline-concordant treatment still unlikely in nonchildren’s hospitals for pediatric CAP
December 19, 2018
This is concerning because the majority of children hospitalized with pneumonia are treated in nonchildren’s hospitals.
![1]()
News
Drug test results ‘should not dictate treatment’
December 13, 2018
BONITA SPRINGS, FLA. – Many clinicians say they’re unsure about interpreting urine drug screens, but a 30-minute training session can make a big difference, said Dr. Rebecca Ann Payne.
News
Acute flaccid myelitis has unique MRI features
November 30, 2018
Acute flaccid myelitis more commonly presents with asymmetric paralysis and spinal cord lesions largely restricted to gray matter.
![1]()
News
Rapid recovery pathway for pediatric PSF/AIS patients
November 26, 2018
Multimodal analgesia with early mobilization may decrease length of stay and improve patient satisfaction.
News
Consider omitting CSF testing in older, low-risk febrile infants
November 17, 2018
To confirm the safety of omitting CSF testing in low-risk febrile infants older than 28 days, a prospective study will be needed.
![1]()
News
New pediatric therapies show promise for influenza, multidrug-resistant pathogens
November 14, 2018
ORLANDO – Baloxavir, a recently approved fast-acting single-dose medication for influenza, is currently under study in children.
![1]()
News
Children are vulnerable to diseases emerging because of climate change
November 13, 2018
ORLANDO – Children are more vulnerable to the health impacts of climate change because of the increased exposure they have to the environment.
![1]()
News
In pediatric ICU, being underweight can be deadly
November 1, 2018
SAN DIEGO – Skinniest patients face the highest mortality risk, even more than the obese and overweight.
![1]()
News
Fever, intestinal symptoms may delay diagnosis of Kawasaki disease in children
October 31, 2018
Consider Kawasaki disease in children who present with unexplained high fever and abdominal pain.
![1]()
News
FDA approves Xofluza for treatment of influenza
October 24, 2018
The FDA has approved Xofluza for acute uncomplicated influenza in people aged 12 years or older who have been symptomatic for 48 hours or less.
